key: cord-0729339-t80by5t9
authors: Lastrucci, Vieri; Bonaccorsi, Guglielmo; Forni, Silvia; D'Arienzo, Sara; Bachini, Letizia; Paoli, Sonia; Lorini, Chiara; Gemmi, Fabrizio
title: The indirect impact of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia in the elderly: a region-wide population-based study in Tuscany, Italy
date: 2021-07-01
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.06.058
sha: 2cac209689524344c807c76d3d4048e9c13831b4
doc_id: 729339
cord_uid: t80by5t9

OBJECTIVE: : to evaluate the indirect effect of COVID-19 large-scale containment measures on the incidence of community-acquired pneumonia (CAP) in the elderly during the first epidemic wave of COVID-19 in Tuscany, Italy. METHODS: : a population based study was carried out on data from the Tuscany healthcare system. The outcome measures were: hospitalization rate for CAP, severity of CAP hospitalizations, and outpatient consumptions of antibacterials for CAP in people aged 65 years and older. Outcome comparisons between corresponding periods of the 2020 and previous years were made. RESULTS: : Compared with the average of the corresponding periods of the previous three years, significant reductions in the weekly hospitalization rates for CAP were observed starting from the week in which the national containment measures were imposed until the end of the first wave of COVID-19 in July. All the antibacterial classes for CAP showed a significant decrease in their outpatient consumptions during the COVID-19 epidemic period. CONCLUSIONS: : The implementation of large-scale COVID-19 containment measures likely reduced the incidence of CAP in the elderly during the first wave of COVID-19 pandemic. Taking into account this indirect impact of pandemic containment measures on respiratory tract infections may improve the planning of health services during a pandemic.

Community acquired pneumonia (CAP) are one of the leading causes of morbidity and mortality among all age groups, but especially among older adults. The most commonly identified pathogens of pneumonia in elderly are bacteria -such as Streptococcus pneumoniae, Haemophilus influenza -and viruses (Bartlett and Mundy, 1995; Feldman, 1999; Fernandez-Sabé, 2003 Thus, to date the impact of a viral respiratory infection pandemic and of the related large scale control measures on the burden of respiratory infectious diseases at community level remains unclear, although its estimation would lead to important implications for the planning and preparedness of health services during a pandemic. Therefore, the aim of the present study is to evaluate the extent to which large-scale containment strategies implemented during COVID-19 pandemic have influenced the incidence of CAP in Tuscany Region (Italy) during the whole first pandemic wave (February -July 2020).

Tuscany is a region in central Italy with an area of about 23,000 square kilometers and a population of more than 3,7 million inhabitants. Italy was one of the first Western countries severely affected by the coronavirus pandemic. The first autochthonous Italian case was identified on 21 February 2020 (Istituto Superiore di Sanità, 2020), but evidences suggest that SARS-CoV-2 was already circulating undetected at the end of 2019 (La . Indeed, a study carried out by the Italian Institute of Health documented the presence of the SARS-Cov-2 in untreated wastewaters of different geographic Italian regions during December 2019. In Tuscany the first case of COVID-19 was observed on the 24th February 2020. During the first wave of the epidemic the Italian Government imposed a three-phased strategy to contain the circulation of SARS-CoV-2 (Lastrucci et al., 2020) . In the first phase, from March 11 to May 3 2020, a national lock-down was adopted, which included the suspension of all non-essential services and activities -including schools -and the imposition of a "stay-at home" order, that banned all non-essential travel and contact with others. Beside these measures, physical distancing rule and the obligation to wear a face mask when leaving home were introduced. These measures resulted to be effective in containing COVID-19 epidemic. In the second phase, from May 4 to June 3 2020, a gradual reopening of services and business was allowed, free movement was granted to all citizens within their Region but movement across Regions were forbidden for non-essential reasons. In phase 3, free movement within the whole national territory was restored and cinemas and theatres reopened, physical distancing rule and face masks remained mandatory, and schools remained closed until September.

This study was conducted in accordance with the Helsinki Declaration. According to the Italian legislation (law 211/2003) and the regional procedures, the study does not need ethical approval as it is a purely observational study on routine collected anonymous data.

This is a cross-sectional retrospective study, based on data from the Tuscany public healthcare system (TPHCS). TPHCS provides universal health coverage for all the Tuscany residents. TPHCS is comprised by a large integrated health care delivery system with 38 secondary level hospitals, 4 university teaching hospitals and about 3.000 general practitioners, that provides comprehensive care for more than 3.7 million residents throughout the whole Region.

Data used for this analysis were derived from the regional healthcare data system that comprises several healthcare data sources; for the present study the outpatient prescriptions and the inpatient hospitalizations registries were used.

As for the outpatient prescriptions registry, records of dispensed drugs for outpatient use are registered at patient-level. Records include patient demographics, information on the dispensed drug (active substance, Anatomical Therapeutic Chemical-ATC code, brand name, formulation), as well as the date of dispensing and the number of dispensed packages.

The primary outcome was the hospitalization rate for CAP not caused by SARS-CoV 2 occurred in people aged 65 or more over the time frame corresponding to the entire first epidemic wave of COVID-19 in Tuscany region (from week 1 to week 27 of 2020). In particular, the ICD-IX-CM principal diagnosis codes registered in the hospital discharge records were used to identify CAP cases; the following ICD-IX-CM principal diagnosis codes were considered: 480xx, 481xx, 482xx, 483xx, 485xx, 486xx, 4870x. The outcome was measured by week (Monday to Sunday) and by considering two distinct periods, the first from week 1 to week 9 (i.e. COVID-19 pre-epidemic period) and the second from week 10 to week 27 (i.e. COVID-19 epidemic period). Considering corresponding periods, the hospitalization rates for CAP in 2020 were compared with the average hospitalization rates for CAP occurred in the previous three years (2017-2019).

Hospitalizations were characterized accordingly to the following covariates: demographics (age and sex) and comorbidity. Comorbidity was measured using the Charlson Comorbidity Index (CCI) (Quan et al., 2011) ). For each analysis, an α level of 0.05 was considered as significant. The statistical software Stata 14 SE (StataCorp LP, College Station, Texas) was used for the data analyses. table 1 ). The amount of the observed decrease in the hospitalization rate for CAP was similar for male and female (-29.6% and -33.6%, respectively) and among the three age-classes considered (-30.4%, -29.1% and -34.0% for 65-74 years, 75-84 years and 85 years and older age-classes, respectively).

As far as characteristics and clinical outcomes of the CAP hospitalizations observed in the preepidemic period are concerned, 46.1% and 9.4% of the CAP hospitalizations had a CCI of 0-1 and 5 and higher, respectively (see table 2 ). Furthermore, in the pre-epidemic period, the ALOS of CAP hospitalizations was 9.1 days, the percentage of hospitalizations requiring ICU was of 1.5%, and the in-hospital mortality was 8.6%. Compared with the previous three years, no significant differences were observed in the ALOS, in the percentage of hospitalizations requiring ICU, and in the in-hospital mortality of CAP hospitalizations occurred in the COVID-19 pre-epidemic period of 2020 (table 2) . As for the COVID-19 epidemic period, 47% and 10.6% of the CAP hospitalizations had a CCI of 0-1 and 5 and higher, respectively (table 2) . Furthermore, in the epidemic period, the ALOS of CAP hospitalizations was 8.9 days, the percentage of hospitalizations requiring ICU was of 1.8%, and the in-hospital mortality was 12.4%. Compared with the previous three years, the distribution of CAP hospitalizations by CCI did not significantly differ in the epidemic period, and significant increases in the percentage of CAP hospitalizations requiring ICU and in the in-hospital mortality of CAP hospitalizations were registered (+51%, 95%CI 1.7-122.83 and 42%, 95%CI 24.19-64.71, respectively). No significant differences in the ALOS of CAP hospitalizations were observed between the epidemic period and the corresponding period of the previous three years (table 2).

In table 3 are reported the age, sex, and CCI standardized ratios for ALOS, hospitalizations requiring ICU, and in-hospital mortality. For all these outcomes, the standardized ratios showed a not significant difference between the observed and the expected results in the pre-epidemic period. As for the COVID-19 epidemic period, the difference between the observed and the expected ALOS of CAP hospitalizations was not significant (SR 1.002, 95%CI 0.97-1.04, p= 0.76).

Although the observed CAP hospitalizations requiring ICU were higher than expected in the epidemic period, this difference was above the level of significance (SR 1. 

The study aimed to evaluate the secondary impact of large-scale containment measures for SARS-COV-2 on the incidence of CAP in the elderly during the first pandemic wave of COVID-19 in Tuscany Region (February-July 2020). To assess the impact on the incidence of CAP in the elderly, The present study has several strengths and limitations. As for the strengths, this is one of the first studies assessing the extent of the impact of SARS-CoV-2 measures on the burden of CAP in the elderly. Furthermore, the study sample represents virtually the whole population of an administrative region with around 3.7 million inhabitants and a wide and varied geographical area.

In particular, the data analysed could be considered as representative of all the hospital care that has been provided to the study population as the regional public health system provides healthcare free of charge for the entire population; private providers play an extremely limited role in the healthcare system of Tuscany, especially in the provision of acute hospital care (Lastrucci et al., 2018) . Similarly, data of antibacterial consumptions in the outpatient setting could be considered as representative of the overall consumptions of Tuscany inhabitants, as the purchase of antibacterials requires a registered prescription of the general practitioner. Lastly, the study adopted a large time-frame period that included the whole first epidemic wave of SARS-CoV-2, this allowed to better compare the trend of the incidence of CAP with the SARS-CoV-2 epidemic situation and the related containment measures implemented. The present study has some limitations. First, although results showed a close association between containment measures and a decrease in CAP, the study design does not allow to assure the causality link between the two phenomena. Second, it was not possible to establish the independent effect of each of the individual containment measures as these were implemented almost simultaneously in the Region. Third, it should be pointed out that although the study results accurately represent the hospitalization rate for CAP in the elderly population, it was not possible to accurately measure the incidence of the whole burden of CAP occurred in the Region as less severe cases treated exclusively in the outpatient setting are not registered in the regional information system; the outpatient consumption of antibacterial drugs for CAP may be considered as a proxy of the incidence of CAP in the outpatients setting only to a limited extent. Nevertheless, it should be underlined that the antibacterial consumptions in the outpatient setting allow to take into account CAP cases occurred for both bacterial and viral pathogens. Indeed, empiric antibacterial treatments in the outpatient setting are recommended in almost all the patients with CAP because bacterial pathogens often coexist with viruses and the current diagnostic tests are not accurate enough or fast enough to ascertain whether CAP is due solely to a virus at the time of presentation (Metlay et al., 2019) . Lastly, as the study was based on routinely collected administrative data, it was not possible to control the quality of the case determination (i.e. the correctness of the coding of cases). However, the quality of TPHCS administrative data in terms of accuracy and reliability is very high as the data are audited each year.

In conclusion, significant decreases in the hospitalization rate and in the outpatient consumptions of antibacterials for CAP were observed in the elderly population during the first wave of COVID-19 pandemic. The timing of these decreases largely coincided with the timing in which epidemic containment measures were first implemented. These findings suggest that the potential benefits of pandemic containment measures can extend beyond the prevention of COVID-19 to include the reduction of the burden of respiratory infectious diseases. Furthermore, results showed a significant increase of in-hospital mortality in patients hospitalized for CAP during the pandemic; such increases in in-hospital mortality may be linked to a delay in seeking care by patients who are afraid of contracting SARS-CoV-2 in the health-care settings, thus efforts should be made to ensure that patients requiring hospital care can obtain it during the pandemic. The above described indirect effects of SARS-CoV-2 containment measures held major implications for the planning and provision of health services during pandemic. Further studies are needed to confirm and characterize these indirect effects of SARS-CoV-2 containment measures on CAP in the elderly population and to better clarify the individual role played by each prevention measure. 

Community-acquired pneumonia

The Impact of the COVID-19 pandemic on hospital admissions in the United States

The Invasive Respiratory Infection Surveillance (IRIS) Initiative reveals significant reductions in invasive bacterial infections during the COVID-19 pandemic

Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic

Impact of Wearing Masks, Hand Hygiene, and Social Distancing on Influenza, Enterovirus, and All-Cause Pneumonia During the Coronavirus Pandemic: Retrospective National Epidemiological Surveillance Study

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

Pneumonia in the elderly

Communityacquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes

The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2

Fear of Covid-19 leads other patients to decline critical treatment

Nonpolio Enterovirus Activity during the COVID-19 Pandemic

Pneumonia guidelines committee of the BTS standards of care committee. BTS guidelines for the management of community acquired pneumonia in adults: update

SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato

Diagnosis-related differences in the quality of end-of-life care: A comparison between cancer and non-cancer patients

Impact of SARS on healthcare utilization by disease categories: implications for delivery of healthcare services

SARS-CoV-2 has been circulating in northern Italy since December 2019: Evidence from environmental monitoring

Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness

The 1918 influenza pandemic: insights for the 21st century

Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries

Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan

Influenza increases invasive meningococcal disease risk in temperate countries

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

The Covid-19 pandemic and the incidence of acute myocardial infarction

Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses

Linee di indirizzo di terapia antibiotica nella pratica del medico di Medicina Generale (paziente adulto). Commissione terapeutica regionale

High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia

WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment

Naming the coronavirus disease (COVID-19) and the virus that causes it

World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19-11

Positive effects of COVID-19 control measures on pneumonia prevention

COVID-19 pandemic and the incidence of community-acquired pneumonia in elderly people

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Not required.

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.